ACADIA Pharmaceuticals Inc. (ACAD)

Healthcare · Biotechnology · NASDAQ

ACADIA Pharmaceuticals Inc. (ACAD) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $5.03B, a trailing price-to-earnings ratio of 38.4 and a free-cash-flow yield of 2.1%. Over the most recent reported fiscal year, revenue grew 11.9% and free cash flow per share fell 34.5%.

Market cap	$5.03B
Trailing P/E	38.4
FCF yield	2.1%
Revenue growth (YoY)	+11.9%
EPS growth (YoY)	-39.0%
FCF/share growth (YoY)	-34.5%
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ACAD data on Nama Insights →

Recent Congressional trades

ACADIA Pharmaceuticals Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Mar 7, 2019